Company / Capital Returned to Shareholders
Viatris Capital Returned to Shareholders History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$500.5M
FY2025
5-year range
$250.0M / $500.5M
FY2021-FY2025
Trend
+100.2%
vs FY2024
Sector context
#13 of 52
Health Care
What the data says
Viatris's capital returned to shareholders of $501M is higher than 75% of companies in the Health Care sector (FY2025). Improved from $250M to $501M over the past 2 years.
Based on SEC 10-K filings.
$501M in FY2025 with a 5-year CAGR of +3.0%. Top quartile in the Health Care sector.
Improved from $250M to $501M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 52This company $500.5M Sector average $1.3B
▼
-62.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.0%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 100.2% year-over-year.
- Ranks #13 out of 52 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $500.5M | +100.2% |
| FY2024 | $250.0M | +0.0% |
| FY2023 | $250.0M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $432.0M | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $432.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026